In:
Therapeutic Apheresis and Dialysis, Wiley, Vol. 26, No. 5 ( 2022-10), p. 969-976
Abstract:
The clinical course of hemodialysis patients with COVID‐19 still remains unclear. Methods Thirty‐four hemodialysis patients were retrospectively enrolled. Patients were divided according to disease severity, and clinical symptoms and laboratory data at admission were compared. Results The serum C‐reactive protein (CRP) level, d ‐dimer level, and white blood cell (WBC) count were significantly higher in the group with critical disease than in the group with mild to severe disease ( p = 0.005, p = 0.039, and p = 0.045). The serum CRP level exceeded 10 mg/dl within 7 days of clinical onset in all the cases with critical disease. Conclusion Hemodialysis patients with COVID‐19 who have elevated serum CRP and d ‐dimer levels, and an elevated WBC count at admission and patients with serum CRP levels exceeding 10 mg/dl before day 7 after clinical onset should be carefully monitored for possible progression to critical disease.
Type of Medium:
Online Resource
ISSN:
1744-9979
,
1744-9987
DOI:
10.1111/1744-9987.13773
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
2010864-3
Bookmarklink